Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI

Journal of Neuroimmunology

Volumn 264, Issue 1-2, 2013, Pages 35-40

  Bell, Jordan C ^a   Liu, Qingwei ^a   Gan, Yan ^a   Liu, Qiang ^a,b   Liu, Yaou ^b   Shi, Fu Dong ^a,b   Turner, Gregory H ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

MRI; Multiple sclerosis; Neuromyelitis Optica; TCR transgenic mice

Indexed keywords

AQUAPORIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEMYELINATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOLOGY; INFLAMMATORY INFILTRATE; MOUSE; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE LESION; PRIORITY JOURNAL; SPINAL NERVE; TRANSGENIC MOUSE;

MRI; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; TCR TRANSGENIC MICE;

ANALYSIS OF VARIANCE; ANIMALS; AQUAPORIN 4; BLOOD-BRAIN BARRIER; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; GADOLINIUM DTPA; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; OPTIC NERVE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPINAL CORD; TIME FACTORS;

EID: 84886776305     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.008     Document Type: Article

References (26)

1. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073-1081.
2. Bettelli E., Baeten D., Jäger A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006, 116:2393-2402.
3. Cree B.A.C., Goodin D.S., Hauser S.L. Neuromyelitis optica. Semin. Neurol. 2002, 22:105-122.
4. Fazekas F., Offenbacher H., Schmidt R., Strasser-Fuchs S. MRI of neuromyelitis optica: evidence for a distinct entity. J. Neurol. Neurosurg. Psychiatry 1994, 57:1140-1142.
5. Filippi M., Rocca M.A., Moiola L., Martinelli V., Ghezzi A., Capra R., Salvi F., Comi G. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 1999, 53:1705-1710.
6. Jarius S., Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat. Rev. Neurol. 2010, 6:383-392.
7. Khanna S., Sharma A., Huecker J., Gordon M., Naismith R.T., Van Stavern G.P. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J. Neuroophthalmol. 2012, 32:216-220.
8. Kinoshita M., Nakatsuji Y., Kimura T., Moriya M., Takata K., Okuno T., Kumanogoh A., Kajiyama K., Yoshikawa H., Sakoda S. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 2009, 386:623-627.
9. Kiyat-Atamer A., Ekizoǧlu E., Tüzün E., Kürtüncü M., Shugaiv E., Akman-Demir G., Eraksoy M. Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients. Eur. J. Neurol. 2013, 20:781-787.
10. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005, 202:473-477.
11. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
12. Mandler R.N., Davis L.E., Jeffery D.R., Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann. Neurol. 1993, 34:162-168.
13. Miller S.D., Karpus W.J., Davidson T.S. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology 2010, (Chapter 15, Unit 15 1). J.E. Coligan (Ed.).
14. Misu T., Fujihara K., Kakita A., Konno H., Nakamura M., Watanabe S., Takahashi T., Nakashima I., Takahashi H., Itoyama Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
15. Papadopoulos M.C., Verkman A.S. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012, 11:535-544.
16. Pau D., Al Zubidi N., Yalamanchili S., Plant G.T., Lee A.G. Optic neuritis. Eye (Lond) 2011, 25:833-842.
17. Pawate S., Sriram S. Isolated longitudinal myelitis: a report of six cases. Spinal Cord 2009, 47:257-261.
18. Pfueller C.F., Paul F. Imaging the visual pathway in neuromyelitis optica. Mult. Scler. Int. 2011, 2011:869814.
19. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuk D.M., Lucchinetti C.F. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
20. Sinnecker T., Dörr J., Pfueller C.F., Harms L., Ruprecht K., Jarius S., Brück W., Niendorf T., Wuerfel J., Friedemann P. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012, 79:708-714.
21. Tashiro K., Ito K., Maruo Y., Homma S., Yamada T., Fujiki N., Moriwaka F. MR imaging of spinal cord in Devic disease. J. Comput. Assist. Tomogr. 1987, 11:516-517.
22. Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003, 60:848-853.
23. Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica. Curr. Treat. Options Neurol. 2005, 7:173-182.
24. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
25. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
26. Zhang H., Bennett J.L., Verkman A.S. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann. Neurol. 2011, 70:943-954.